Evidence map›Paper›PMID 24406461›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2014

Horizon scanning for translational genomic research beyond bench to bedside.

Mindy Clyne, Sheri D Schully, W David Dotson, Michael P Douglas, Marta Gwinn, Katherine Kolor, Anja Wulf, M Scott Bowen, Muin J Khoury

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. The current state of funded NIH grants in implementation science in genomic medicine: a portfolio analysis.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  7. A logic model for precision medicine implementation informed by stakeholder views and implementation science.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  8. Review
  9. Using deep learning to identify translational research in genomic medicine beyond bench to bedside.Database : the journal of biological databases and curation · 2019
    Article
  10. Article
  11. The current state of implementation science in genomic medicine: opportunities for improvement.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Review
  12. Article
  13. A knowledge base for tracking the impact of genomics on population health.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  14. Scanning the human genome and the horizon: the potential and pitfalls of pharmacogenetics and stratified medicine.The British journal of general practice : the journal of the Royal College of General Practitioners · 2015
    Article
  15. Article
  16. Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2015
    Article
  17. Article
  18. Evidence synthesis and guideline development in genomic medicine: current status and future prospects.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Article
  19. Article
  20. Medicine. Big data meets public health.Science (New York, N.Y.) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mindy Clyne1] Kelly Services, Troy, Michigan, USA [2] Epidemiology and Genomics Research Program, National Cancer Institute, Bethesda, Maryland, USA.
Sheri D SchullyEpidemiology and Genomics Research Program, National Cancer Institute, Bethesda, Maryland, USA.
W David DotsonOffice of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Michael P Douglas1] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA [2] McKing Consulting Corporation, Atlanta, Georgia, USA.
Marta Gwinn1] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA [2] McKing Consulting Corporation, Atlanta, Georgia, USA.
Katherine KolorOffice of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Anja Wulf1] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA [2] Cadence Group, Atlanta, Georgia, USA.
M Scott BowenOffice of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Muin J Khoury1] Epidemiology and Genomics Research Program, National Cancer Institute, Bethesda, Maryland, USA [2] Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

purposeThe dizzying pace of genomic discoveries is leading to an increasing number of clinical applications. In this report, we provide a method for horizon scanning and 1 year data on translational research beyond bench to bedside to assess the validity, utility, implementation, and outcomes of such applications.

methodsWe compiled cross-sectional results of ongoing horizon scanning of translational genomic research, conducted between 16 May 2012 and 15 May 2013, based on a weekly, systematic query of PubMed. A set of 505 beyond bench to bedside articles were collected and classified, including 312 original research articles; 123 systematic and other reviews; 38 clinical guidelines, policies, and recommendations; and 32 articles describing tools, decision support, and educational materials.

resultsMost articles (62%) addressed a specific genomic test or other health application; almost half of these (n = 180) were related to cancer. We estimate that these publications account for 0.5% of reported human genomics and genetics research during the same time.

conclusionThese data provide baseline information to track the evolving knowledge base and gaps in genomic medicine. Continuous horizon scanning of the translational genomics literature is crucial for an evidence-based translation of genomics discoveries into improved health care and disease prevention.

Indexed as

Decision Support TechniquesEvidence-Based MedicineGenomicsTranslational Research, BiomedicalCross-Sectional StudiesHumansInformation DisseminationMeta-Analysis as Topic

Identifiers

PMID24406461
PMCPMC4079725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.